SILK RD MED INC's ticker is SILK and the CUSIP is 82710M100. A total of 168 filers reported holding SILK RD MED INC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $639,938 | -57.8% | 42,691 | -8.4% | 0.00% | -50.0% |
Q2 2023 | $1,514,879 | -18.4% | 46,626 | -1.7% | 0.00% | -33.3% |
Q1 2023 | $1,856,758 | -23.0% | 47,451 | +4.0% | 0.00% | -25.0% |
Q4 2022 | $2,412,338 | +22.2% | 45,645 | +4.1% | 0.00% | +33.3% |
Q3 2022 | $1,974,000 | +21.3% | 43,864 | -2.0% | 0.00% | 0.0% |
Q2 2022 | $1,628,000 | -8.1% | 44,740 | +4.3% | 0.00% | +50.0% |
Q1 2022 | $1,772,000 | -10.6% | 42,906 | -7.8% | 0.00% | 0.0% |
Q4 2021 | $1,983,000 | -20.1% | 46,533 | +3.1% | 0.00% | -33.3% |
Q3 2021 | $2,483,000 | +11.0% | 45,119 | -3.5% | 0.00% | 0.0% |
Q2 2021 | $2,237,000 | +7.3% | 46,741 | +13.5% | 0.00% | 0.0% |
Q1 2021 | $2,085,000 | -19.8% | 41,166 | -0.3% | 0.00% | -25.0% |
Q4 2020 | $2,600,000 | -4.9% | 41,290 | +1.4% | 0.00% | 0.0% |
Q3 2020 | $2,735,000 | +36.3% | 40,700 | -15.0% | 0.00% | 0.0% |
Q2 2020 | $2,007,000 | +162.4% | 47,910 | +97.3% | 0.00% | +100.0% |
Q1 2020 | $765,000 | -22.9% | 24,287 | -1.1% | 0.00% | 0.0% |
Q4 2019 | $992,000 | +67.3% | 24,562 | +34.8% | 0.00% | +100.0% |
Q3 2019 | $593,000 | +14.3% | 18,227 | +70.1% | 0.00% | 0.0% |
Q2 2019 | $519,000 | – | 10,717 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTORAL ASSET MANAGEMENT INC | 399,483 | $25,159,000 | 1.77% |
NEXT CENTURY GROWTH INVESTORS LLC | 313,534 | $19,746,000 | 1.66% |
Graticule Asia Macro Advisors LLC | 52,565 | $3,311,000 | 1.59% |
Bullseye Asset Management LLC | 58,112 | $3,659,000 | 1.36% |
EMC Capital Management | 24,598 | $1,549,000 | 1.18% |
Parkman Healthcare Partners LLC | 67,854 | $4,273,000 | 1.10% |
Nicholas Investment Partners, LP | 219,483 | $13,823,000 | 1.07% |
SCHOLTZ & COMPANY, LLC | 37,517 | $2,363,000 | 0.92% |
WASATCH ADVISORS LP | 2,630,013 | $165,638,000 | 0.82% |
Rhenman & Partners Asset Management AB | 125,000 | $7,873,000 | 0.64% |